MedPath

the effect of pilocarpine 1% eye drop on the relative improvement of presbyopia

Phase 3
Recruiting
Conditions
presbyopia.
Presbyopia
H52.4
Registration Number
IRCT20240325061363N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients aged 40-60 years
Suffering from presbyopia
Uncorrected near visual acuity: 20/40 to 20/100

Exclusion Criteria

Eye diseases (including glaucoma, cataracts, amblyopia, high myopia, eye trauma, congenital pupil abnormalities, corneal opacity, intraocular surgeries)
Severe sensitivity and side effects to eye drops
Taking drugs that interact with pilocarpine

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ncorrected near visual acuity and uncorrected distance visual acuity. Timepoint: Before the intervention, 20 minutes later, one hour and six hours later, as well as on the 14th and 30th days. Method of measurement: Snellen chart.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath